University Hospitals Seidman Cancer Center treats its first glioblastoma patient with genetically modified poliovirus

University Hospitals Seidman Cancer Center treated its first patient in a new clinical trial to validate the groundbreaking effects of the poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain.

UH is the only Midwest site participating in this clinical trial, which was initiated at Duke Cancer Institute in Durham, NC. The original study, which ran from 2012-2017, was published in New England Journal of Medicine in July 2018 as well as highlighted on “60 Minutes” in 2015 and again in 2018. The study found that survival rates were significantly higher in glioblastoma patients who received an intratumoral infusion of a modified viral chimera combining the polio and rhinoviruses (PVSRIPO immunotherapy) compared to patients receiving standard treatment at the same institution.

Guiding Lights: UC San Diego Launches Center for Fluorescence-Guided Surgery

UC San Diego launches new Center for Fluorescence-Guided Surgery. The center builds upon Roger Tsien’s legacy, delivering a new caliber of surgical precision to treat patients with tumors and disease of all types, identifying unhealthy tissues with a fluorescent glow.

A Rare Diagnosis Leads to a Successful Surgery and Recovery

Drew, a 65-year-old man from Connecticut, was diagnosed with a spinal dural arteriovenous fistula (SDAVF), which is a rare vascular malformation of the spinal cord that only affects 1 in every 200,000 people.

SDAVFs are underdiagnosed because symptoms can be vague and mirror many other types of medical problems. If left untreated, SDAVFs can result in permanent spinal cord injury.

Despite the uncommon diagnosis, a multidisciplinary care team from Nuvance Health, including primary care, neurology, radiology, and neurosurgery correctly and expeditiously identified and surgically treated Drew’s SDAVF.

The CNS Announces a New Addition to its NEUROSURGERY® Publications Suite of Journals

The Congress of Neurological Surgeons (CNS) is pleased to announce the debut of its latest journal, Neurosurgery Open. The goal of Neurosurgery Open is to provide an outlet for the publication of scientific papers dealing with clinical neurosurgery and experimental neurosurgery

Microvention Funds $250,000 Educational Grant for the Advancement of Endovascular Education and Technology to the CNS Foundation

MicroVention, one of the world’s fastest growing medical device companies, has granted $250,000 to the Congress of Neurological Surgeons Foundation (CNS Foundation). This generous gift will fund educational programs dedicated toward the advancement of the field of endovascular education and technology.

CNS Gift to the CNS Foundation Doubles Innovative Clinical Research Initiative, Creating Annual NINDS/CNSF K12 Scholar Awards

The Congress of Neurological Surgeons Foundation (CNS Foundation) announced a second K12 award will be funded by a generous gift from the Congress of Neurological Surgeons (CNS). The award is made possible through a collaboration with the Foundation of the National Institutes of Health (FNIH) and the National Institutes of Health (NIH).

Three UC San Diego Researchers Receive Top Honors with NIH Director’s Awards

Three University of California San Diego researchers have received prestigious awards through the National Institutes of Health (NIH) High-Risk, High-Reward Research Program, including the Pioneer Award, the program’s top honor.

Congress of Neurological Surgeons Hosts 2019 Annual Meeting in San Francisco, October 19–23

Schaumburg, Illinois, August 21, 2019 — The Congress of Neurological Surgeons (CNS) is proud to host its 67th Annual Meeting in San Francisco, California, October 19–23. Each year, thousands of neurosurgeons, advanced practice providers, health care advocates, and other professionals from around the world gather to celebrate and learn about the advances are being made in the field of neurosurgery.

CNS Publishes Guidelines for Pediatric Myelomeningocele

The Congress of Neurological Surgeons (CNS) has developed an evidence-based guideline for the treatment of patients with myelomeningocele. Executive summaries of the Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Pediatric Myelomeningocele were published today in Neurosurgery. Full text of the guidelines can also be found on cns.org.

Carroll, Kalanithi, Kearns Goodwin, Skloot, Stephens, Vedantam, and Zimmer Headline the 2019 CNS Annual Meeting

An inspiring lineup of guest speakers will address thousands of leading neurosurgeons from around the world at the Congress of Neurological Surgeons 2019 Annual Meeting in San Francisco, California on October 19–23. The chosen speakers are known for their leadership and expertise in healthcare, science, and journalism.

Mount Sinai Ranked Among the Top in the Nation by U.S. News & World Report

The Hospital was ranked No. 14 nationally, up four spots from last year. Eight departments within the Hospital were ranked among the top 20 nationally in their specialties, up from five last year

The Congress of Neurological Surgeons Approves $1 Million Gift to the CNS Foundation

The Executive Committee of the Congress of Neurological Surgeons (CNS) voted unanimously during its winter Executive Committee meeting to approve a $1 million gift to the Congress of Neurological Surgeons Foundation (CNS Foundation). The CNS Foundation’s mission is to improve worldwide patient health by supporting innovative programs that allow neurosurgeons to collaborate globally as researchers, learners, educators and caregivers.